BV
Bandi Vamsikrishna
About Bandi Vamsikrishna
Data last updated:
Bandi Vamsikrishna has 21 years in corporate governance. Holds Partner and Designated Partner roles. Currently with 32 companies, including Multiples Private Equity Fund Ii Llp and Allita Finvest And Advisors Llp. Formerly with 32 companies, such as Mainland Digital Technologies Llp and Dyumat Hotels Llp. Engaged in General Business, Healthcare and more. The 11 current companies with reported revenue have a combined latest revenue of ₹22,948 Cr; the largest is Hetero Labs Limited at ₹16,537 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Hetero Labs Limited U24110TG1989PLC009723 | Managing Director | 10 Apr 2008 | 1989 | ₹16,537 Cr (FY 2025) | Active |
| Hetero Drugs Limited U24230TG1993PLC015582 | Director | 10 Apr 2008 | 1993 | ₹3,324 Cr (FY 2025) | Active |
 Hetero Healthcare Limited U52520TG2006PLC049614 | Director | 10 Apr 2008 | 2006 | ₹1,190 Cr (FY 2025) | Active |
 Jurala Organic Farms And Agro Industries Private Limited U20119TS2023PTC175673 | Director | 02 Aug 2023 | 2023 | ₹1,053 Cr (FY 2025) | Active |
 Aspiro Pharma Limited U24100TG2014PLC092771 | Director | 13 Feb 2014 | 2014 | ₹418 Cr (FY 2025) | Active |
| Hetero Biopharma Limited U24290TG2016PLC111946 | Director | 25 Mar 2021 | 2016 | ₹387 Cr (FY 2024) | Active |
 Multiples Private Equity Fund Ii Llp AAD-7466 | Partner | 05 Jun 2015 | 2015 | ₹31.11 Cr (FY 2025) | Active |
| Hetero Plasma Sciences Private Limited U46497TS2023PTC175917 | Additional Director | 15 Oct 2025 | 2023 | ₹4.83 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Mainland Digital Technologies Llp AAO-6124 | Designated Partner | 25 Mar 2019 | 2019 | – | Active |
| Dyumat Hotels Llp AAX-8161 | Designated Partner | 16 Jul 2021 | 2021 | – | Active |
| Jitvan Land Llp AAX-8165 | Designated Partner | 16 Jul 2021 | 2021 | – | Active |
| Designated Partner | – | 2021 | – | Converted And Dissolved | |
| Chemi Pack (India) Private Limited U21023TG2007PTC054088 | Additional Director | 19 Nov 2009 | 2007 | ₹66.09 Cr (FY 2024) | Active |
 Symed Labs Limited U24231TG1998PLC029961 | Additional Director | 10 Apr 2008 | 1998 | ₹792 Cr (FY 2025) | Amalgamated |
| Sri Sai Karuna Industrys Limited U24232TG2011PLC074274 | Director | 04 May 2011 | 2011 | – | Converted To Llp |
 Honour Lab Limited U24233TG2011PLC077561 | Director | 21 Nov 2011 | 2011 | ₹2,483 Cr (FY 2025) | Active |
| Xiva Heallth Care Private Limited U24230TG2004PTC044710 | Director | 29 Nov 2004 | 2004 | – | Strike Off |
| Hetero Bio Chemicals Limited U24299TG2008PLC058020 | Director | 06 Mar 2008 | 2008 | – | Strike Off |
| Shri Bhramarambikas Industrys Limited U74900TG2008PLC058017 | Director | 07 Apr 2011 | 2008 | ₹4,716 Cr (FY 2016) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bandi Vamsikrishna
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bandi Vamsikrishna
Bandi Vamsikrishna has 21 years in corporate governance. Holds Partner and Designated Partner roles. Currently with 32 companies, including Multiples Private Equity Fund Ii Llp and Allita Finvest And Advisors Llp. Formerly with 32 companies, such as Mainland Digital Technologies Llp and Dyumat Hotels Llp. Engaged in General Business, Healthcare and more. The 11 current companies with reported revenue have a combined latest revenue of ₹22,948 Cr; the largest is Hetero Labs Limited at ₹16,537 Cr (FY 2025).
Bandi Vamsikrishna is associated with 32 companies as Partner and Designated Partner, including Hetero Labs Limited (₹16,537 Cr), Hetero Drugs Limited (₹3,324 Cr), Hetero Healthcare Limited (₹1,190 Cr).
Bandi Vamsikrishna has expertise in General Business, Healthcare and other sectors.
Bandi Vamsikrishna has 21 years in corporate governance.
By reported revenue, the largest current company of Bandi Vamsikrishna is Hetero Labs Limited, with revenue of ₹16,537 Cr (FY 2025).
The 11 current companies of Bandi Vamsikrishna that report revenue have a combined latest revenue of ₹22,948 Cr.
Bandi Vamsikrishna currently holds positions at 32 companies; the 5 largest by reported revenue are Hetero Labs Limited (₹16,537 Cr), Hetero Drugs Limited (₹3,324 Cr), Hetero Healthcare Limited (₹1,190 Cr), Jurala Organic Farms And Agro Industries Private Limited (₹1,053 Cr), Aspiro Pharma Limited (₹418 Cr).